Gillian Woollett’s Research Published in BioDrugs
Summary
Gillian Wollett, Senior Vice President of Avalere’s FDA & Regulatory Policy team, recently published “A ‘Global Reference’ Comparator for Biosimilar Development” in BioDrugs.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
The article is available online.
Rare Disease Day Webinar: Voices that move systems
Access the webinar replay offering actionable, cross-geography insights on how patient and caregiver voices can improve diagnosis, engagement, and outcomes.
Replay